+632.5%
AXON vs BBIO
+148.5%
+484.0%
-60.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.1% | +1.8% | -4.8% | -3.3% |
| 7D | -3.3% | -0.5% | -2.8% | -3.3% |
| 30D | -17.8% | -10.1% | -7.7% | -16.6% |
| 3M | +8.3% | +12.4% | -4.1% | +6.2% |
| 6M | -12.4% | +15.9% | -28.3% | -14.8% |
| YTD | -13.7% | -0.5% | -13.2% | -14.5% |
| 1Y | -33.1% | +42.2% | -75.3% | -37.2% |
| 3Y | +128.2% | +167.8% | -39.6% | +88.8% |
| 5Y | +170.5% | +49.6% | +120.9% | +93.0% |
| All | +632.5% | +148.5% | +484.0% | +286.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling